On a hut trip to the Selkirk Mountains some eleven years ago,Meghan Kelly, one of the strongest telemark skiers of her ...

This week’s Careers newsletter includes ways to manage stress and anxiety during a job interview, an interview with Colin ...

#Texans assistant GM James Liipfert is slated to fly to Atlanta for a second, in-person interview for the #Falcons vacant GM ...

Applied Digital (APLD) shares surged as high as 15% during morning market action on Thursday after its second quarter fiscal 2026 results topped estimates and the company revealed it was in advanced ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Leadership roles require strategy and business sense more than daily operational know-how, ...

The unemployment rate remains low but rose to its highest level since 2021. The federal government released two major economic reports this week, easing a backlog of data pent up by the 43-day ...

Applied Digital (APLD) plunged 17.5% with no company-specific news after gaining 200% year-to-date. Applied Digital designs and operates AI data centers. Applied Digital issued $2.35B in 9.25% senior ...

Chris Mooney is a Pulitzer Prize-winning journalist and a CNN Climate contributor. He is currently a professor of practice in the Environmental Institute at the University of Virginia. Planet-warming ...

COLUMBUS, Ohio (WCMH) — A report linked Amazon data centers to miscarriages and rare cancers, drawing concerns about data centers’ presence in central Ohio. According to a report from Rolling Stone, ...

The Monterey Park City Council this week postponed a key vote on a controversial, proposed data center in town, amid public demands for more time to weigh in on the project. The center, if ultimately ...

Marvell clearly has visibility into big financial opportunities, but analysts wonder about its competitive positioning and the impact of a newly announced deal Marvell's stock was up about 8% on ...

Almost exactly one year ago, Janux Therapeutics unveiled early data for its investigational T-cell engager that wowed investors and analysts alike. But the biotech’s newest update has failed to garner ...